In light of the fact that adenosine generated via CD73 suppresses anti-tumor effector T cell function, these findings suggest that providing sufficient CD28 signaling in the tumor microenvironment can inhibit CD73 expression on CD8+ T cells thereby promotes anti-tumor immunity. This evidence concerns the gene CD28 and neoplasm.